The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process
Open accessAbstract
Presynaptic, plasma membrane serotonin (5-hydroxytryptamine; 5-HT) transporters (SERTs) clear 5-HT following vesicular release and are regulated through trafficking-dependent pathways. Recently, we provided evidence for a trafficking-independent mode of SERT regulation downstream of adenosine receptor (AR) activation that is sensitive to p38 MAPK inhibitors. Here, we probe this pathway in greater detail, demonstrating elevation of 5-HT transport by multiple p38 MAPK activators (anisomycin, H(2)O(2), and UV radiation), in parallel with p38 MAPK phosphorylation, as well as suppression of anisomycin stimulation by p38 MAPK siRNA treatments. Studies with transporter-transfected Chinese hamster ovary cells reveal that SERT stimulation is shared with the human norepinephrine transporter but not the human dopamine transporter. Saturation kinetic analyses of anisomycin-SERT activity reveal a selective reduction in 5-HT K(m) supported by a commensurate increase in 5-HT potency (K(i)) for displacing surface antagonist binding. Anisomycin treatments that stimulate SERT activity do not elevate surface SERT surface density whereas stimulation is lost with preexposure of cells to the surface-SERT inactivating reagent, 2-(trimethylammonium)ethyl methane thiosulfonate. Guanylyl cyclase (1H-(1,2,4)-oxadiazolo[4,3-a]-quinoxalin-1-one) and protein kinase G inhibitors (H8, DT-2) block AR stimulation of SERT yet fail to antagonize SERT stimulation by anisomycin. We thus place p38 MAPK activation downstream of protein kinase G in a SERT-catalytic regulatory pathway, distinct from events controlling SERT surface density. In contrast, the activity of protein phosphatase 2A inhibitors (fostriecin and calyculin A) to attenuate anisomycin stimulation of 5-HT transport suggests that protein phosphatase 2A is a critical component of the pathway responsible for p38 MAPK up-regulation of SERT catalytic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, inflammatory cytokines, including IL-6, have been shown to increase 5-HTT expression and function (Morikawa et al., 1998, Mossner et al., 1998, Sakai et al., 2003, Tsao et al., 2008) (see Figure 1), an effect found to be mediated by induction of p38 mitogen-activated protein kinase (MAPK), both in vitro and in vivo (Zhu et al., 2005, Zhu et al., 2006, Zhu et al., 2010a).”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Zhu et al., 2005
In the citing paper
“Cytokines also influence the synthesis of monoamines through disruption of tetrahydrobiopterin, an essential enzyme co-factor to hydroxylases involved in monoamine synthesis.”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [90]
In the citing paper
“Furthermore, they can modulate serotonin signaling by increasing the expression and function of monoamine transporters which perform the re-uptake of synaptic serotonin (89–92).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,400
Signaling Through Scaffold, Anchoring, and Adaptor Proteins
Pawson, T., & Scott, J. D. (1997) · Science · doi:10.1126/science.278.5346.2075 · Cited by 2,256
Organization and regulation of mitogen-activated protein kinase signaling pathways
Garrington, T. P., & Johnson, G. L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80028-3 · Cited by 1,268
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933
Self-citationRole of serotonin in the pathophysiology of depression: focus on the serotonin transporter
Owens, M. J., & Nemeroff, C. B. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.2.288 · Cited by 932
Cloning and expression of a functional serotonin transporter from rat brain
Blakely, R., Berson, H. E., Fremeau, R. T., Caron, M. G., Peek, M. M., Prince, H. K., & Bradley, C. C. (1991) · Nature · doi:10.1038/354066a0 · Cited by 831
Self-citationCloning of a Serotonin Transporter Affected by Antidepressants
Hoffman, B. J., Mezey, É., & Brownstein, M. (1991) · Science · doi:10.1126/science.1948036 · Cited by 614
Bruno Giros, A., Mestikawy, S. E., Godinot, N., Zheng, K., Han, H. J., Yang-Feng, T. L., & Caron, M. G. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08925-4 · Cited by 477
Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics
Murphy, D. L. (2004) · Molecular Interventions · doi:10.1124/mi.4.2.8 · Cited by 457
Flagged first, then by citations
Research works printed but not linked: 5
- Launay, 1994, Am. J. Physiol., 266, R526
- Apparsundaram, 2001, J. Pharmacol. Exp. Ther., 299, 666
- Somwar, 2001, Biochem. J., 359, 639, 10.1042/bj3590639 · DOI
- Giros, 1992, Mol. Pharmacol., 42, 383
- Whitworth, 2002, J. Neurosci., 22, 1
Cited by
Sorted by citations
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
Miller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 874
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
Miller, A. H., Ancoli‐Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7805 · Cited by 625
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 569
Zhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549
Self-citationShelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511
Depression in cancer patients: Pathogenesis, implications and treatment (Review)
Smith, H. R. (2015) · Oncology Letters · doi:10.3892/ol.2015.2944 · Cited by 526
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 474
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 447
Sutcliffe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L., Li, C., Folstein, S. E., & Blakely, R. D. (2005) · The American Journal of Human Genetics · doi:10.1086/432648 · Cited by 392
Self-citationFelger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 413
Raison, C. L., Borisov, A. S., Majer, M., Drake, D. F., Pagnoni, G., Woolwine, B. J., Vogt, G. J., Massung, B., & Miller, A. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.010 · Cited by 367
Cytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339
Zhu, C.-B., Lindler, K. M., Owens, A. W., Daws, L. C., Blakely, R. D., & Hewlett, W. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.116 · Cited by 317
Self-citationKinase cascades and ligand-directed signaling at the kappa opioid receptor
Bruchas, M. R., & Chavkin, C. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1806-y · Cited by 321
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
A Dialogue between the Immune System and Brain, Spoken in the Language of Serotonin
Baganz, N. L., & Blakely, R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300186b · Cited by 316
Self-citationp38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1
He, Y., She, H., Zhang, T., Xu, H., Cheng, L., Yepes, M., Zhao, Y., & Mao, Z. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201701049 · Cited by 293
The solute carrier 6 family of transporters
Bröer, S., & Gether, U. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01975.x · Cited by 277
Bruchas, M. R., Schindler, A. G., Shankar, H., Messinger, D. I., Miyatake, M., Land, B. B., Lemos, J. C., Hagan, C. E., Neumaier, J. F., Quintana, A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.011 · Cited by 273
Miller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
Shelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 264
Role of Inflammation in Suicide: From Mechanisms to Treatment
Brundin, L., Bryleva, E. Y., & Thirtamara Rajamani, K. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.116 · Cited by 257
“IL-1 β and TNF-α have been shown to enhance the expression and activation of serotonin transporters in cell lines via a p38 mitogen-activated protein kinase pathway (Mossner et al , 1998; Ramamoorthy et al , 1995; Zhu et al , 2006; Zhu et al , 2005).”
Bufalino, C., Hepgul, N., Aguglia, E., & Pariante, C. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.04.009 · Cited by 228
On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
Roohi, E., Jaafari, N., & Hashemian, F. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02100-7 · Cited by 256
Ma, K., Zhang, H., & Baloch, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050733 · Cited by 208
Toxoplasma gondii‐induced neuronal alterations
Parlog, A., Schlüter, D., & Dunay, I. R. (2014) · Parasite Immunology · doi:10.1111/pim.12157 · Cited by 199
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons
Ehrich, J. M., Messinger, D. I., Knakal, C. R., Kuhar, J. R., Schattauer, S. S., Bruchas, M. R., Zweifel, L. S., Kieffer, B. L., Phillips, P. E. M., & Chavkin, C. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2444-15.2015 · Cited by 187
Carneiro, A. M. D., Cook, E. H., Murphy, D. L., & Blakely, R. D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33374 · Cited by 180
Self-citationPrasad, H. C., Zhu, C.-B., McCauley, J. L., Samuvel, D. J., Ramamoorthy, S., Shelton, R. C., Hewlett, W. A., Sutcliffe, J. S., & Blakely, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501432102 · Cited by 178
Self-citationThe role of the immune system in posttraumatic stress disorder
Katrinli, Ş., Oliveira, N. C. D. S., Felger, J. C., Michopoulos, V., & Smith, A. K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02094-7 · Cited by 201
Vesicular and Plasma Membrane Transporters for Neurotransmitters
Blakely, R. D., & Edwards, R. H. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005595 · Cited by 169
Self-citationRudnick, G., Krämer, R., Blakely, R., Murphy, D. L., & Verrey, F. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1410-1 · Cited by 162
Self-citationMorris, G., Berk, M., Gałecki, P., Walder, K. R., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 163
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Regulation of monoamine transporters: Role of transporter phosphorylation
Ramamoorthy, S., Shippenberg, T. S., & Jayanthi, L. D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.009 · Cited by 151
Gu, W., Song, L., Li, X.-M., Wang, D., Guo, X., & Xu, W. (2015) · Scientific Reports · doi:10.1038/srep08733 · Cited by 147
Baumeister, D., Russell, A., Pariante, C. M., & Mondelli, V. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0887-z · Cited by 142
Inflammation in depression: is adiposity a cause?
Shelton, R. C., & Miller, A. H. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/rshelton · Cited by 143
The Immune System and the Role of Inflammation in Perinatal Depression
Leff, P., Mancilla‐Herrera, I., Flores‐Ramos, M., Cruz-Fuentes, C. S., Reyes‐Grajeda, J. P., García-Cuétara, M. D. P., Bugnot-Pérez, M. D., & Pulido-Ascencio, D. E. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0048-3 · Cited by 135
Veenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128
Self-citationGoing with the Flow: Trafficking‐Dependent and ‐Independent Regulation of Serotonin Transport
Steiner, J. A., Carneiro, A. M. D., & Blakely, R. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00757.x · Cited by 127
Self-citationEnhanced activity of human serotonin transporter variants associated with autism
Prasad, H. C., Steiner, J. A., Sutcliffe, J. S., & Blakely, R. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0143 · Cited by 126
Self-citationMalynn, S., Campos‐Torres, A., Moynagh, P. N., & Haase, J. K. (2013) · Neurochemical Research · doi:10.1007/s11064-012-0967-y · Cited by 129
Schindler, A. G., Messinger, D. I., Smith, J. S., Shankar, H., Gustin, R. M., Schattauer, S. S., Lemos, J. C., Chavkin, N. W., Hagan, C. E., Neumaier, J. F., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3220-12.2012 · Cited by 122
Ontogeny and regulation of the serotonin transporter: Providing insights into human disorders
Daws, L. C., & Gould, G. G. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.013 · Cited by 121
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome
Deng, H., Chen, Y., Xing, J., Zhang, N., & Xu, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1470283 · Cited by 146
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Pandey, G. N., Rizavi, H. S., Zhang, H., Bhaumik, R., & Ren, X. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170192 · Cited by 113
Jayanthi, L. D., Samuvel, D. J., Blakely, R. D., & Ramamoorthy, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009555 · Cited by 123
Self-citationKong, E., Sučić, S., Monje, F. J., Reisinger, S. N., Savalli, G., Diao, W., Khan, D., Ronovsky, M., Cabatic, M., Koban, F., et al. (2015) · Scientific Reports · doi:10.1038/srep09009 · Cited by 114
PCOS and Depression: Common Links and Potential Targets
Kolhe, J. V., Chhipa, A. S., Butani, S., Chavda, V. K., & Patel, S. S. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00765-2 · Cited by 126
Maes, M. H. J., Leonard, B. E., Fernandez, A., Kubera, M., Nowak, G., Veerhuis, R., Gardner, A., Ruckoanich, P., Geffard, M., Altamura, C. A., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.019 · Cited by 103
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters
Bermingham, D. P., & Blakely, R. D. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012260 · Cited by 97
Self-citationRoy, S. M., Grum-Tokars, V. L., Schavocky, J. P., Saeed, F., Staniszewski, A., Teich, A. F., Arancio, O., Bachstetter, A. D., Webster, S. J., Van Eldik, L. J., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00002 · Cited by 99
Tayab, M. A., Islam, M. N., Chowdhury, K. A. A., & Tasnim, F. M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112668 · Cited by 100
Dempsie, Y., Morecroft, I., Welsh, D., MacRitchie, N. A., Herold, N., Loughlin, L., Nilsen, M., Peacock, A. J., Harmar, A. J., Bäder, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.767558 · Cited by 96
Robson, M. J., Quinlan, M. A., & Blakely, R. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00412 · Cited by 96
Self-citationModulation of the trafficking of the human serotonin transporter by human alpha‐synuclein
Wersinger, C., Rusnak, M., & Sidhu, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04900.x · Cited by 93
Rege, S., & Hodgkinson, S. J. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413499077 · Cited by 90
Role of Inflammation in Depression and Treatment Implications
Felger, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_166 · Cited by 94
Sitte, H. H., & Freissmuth, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06474.x · Cited by 86
Smith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84
Biogenic Amine Neurotransmitter Transporters: Just When You Thought You Knew Them
Blakely, R., DeFelice, L. J., & Galli, A. (2005) · Physiology · doi:10.1152/physiol.00013.2005 · Cited by 82
Self-citationChang, J. C., Tomlinson, I. D., Warnement, M. R., Ustione, A., Carneiro, A. M. D., Piston, D. W., Blakely, R., & Rosenthal, S. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0048-12.2012 · Cited by 78
Self-citationMalemud, C. J., & Miller, A. H. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.2.171 · Cited by 78
Katafuchi, T., Kondo, T., Take, S., & Yoshimura, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04478.x · Cited by 78
Bachstetter, A. D., Bodnar, C., & Morganti, J. M. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238604 · Cited by 85
Mice Genetically Depleted of Brain Serotonin Do Not Display a Depression-like Behavioral Phenotype
Angoa‐Pérez, M., Kane, M. J., Briggs, D. I., Herrera‐Mundo, N., Sykes, C. E., Francescutti, D. M., & Kuhn, D. M. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500096g · Cited by 68
Habenular Kiss1 Neurons Modulate the Serotonergic System in the Brain of Zebrafish
Ogawa, S., Ng, K. W., Ramadasan, P. N., Nathan, F. M., & Parhar, I. S. (2012) · Endocrinology · doi:10.1210/en.2012-1062 · Cited by 66
Ehrich, J. M., Phillips, P. E. M., & Chavkin, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.157 · Cited by 65
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions
Lacivita, E., Perrone, R., Margari, L., & Leopoldo, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00965 · Cited by 66
Takahashi, Y., Nishimura, T., Higuchi, K., Noguchi, S., Tega, Y., Kurosawa, T., Deguchi, Y., & Tomi, M. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2532-0 · Cited by 61
Hypothalamic-pituitary-adrenal axis function during perinatal depression
Leff, P., Flores‐Ramos, M., López‐Martínez, M., Cruz-Fuentes, C. S., & Reyes‐Grajeda, J. P. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1508-2 · Cited by 67
Zhang, Y., Gesmonde, J. F., Ramamoorthy, S., & Rudnick, G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0034-07.2007 · Cited by 60
Cross, S. J., Kim, S., Weiss, L. A., Delahanty, R., Sutcliffe, J. S., LEVENTHAL, B. L., Cook, E. H., & Veenstra-VanderWeele, J. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301406 · Cited by 60
Boudreau, R. T. M., Conrad, D., & Hoskin, D. W. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.030 · Cited by 58
Rapid Stimulation of Presynaptic Serotonin Transport by A3 Adenosine Receptors
Zhu, C.-B., Steiner, J. A., Munn, J. L., Daws, L. C., Hewlett, W. A., & Blakely, R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121665 · Cited by 58
Self-citationRobson, M. J., Quinlan, M. A., Margolis, K. G., Gajewski-Kurdziel, P. A., Veenstra-VanderWeele, J. M., Gershon, M. D., Watterson, D. M., & Blakely, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809137115 · Cited by 58
Self-citationBrain Cytokines and the 5‐HT System during Poly I:C‐Induced Fatigue
Katafuchi, T., Kondo, T., Take, S., & Yoshimura, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.020 · Cited by 56
Rose’Meyer, R. B. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-37 · Cited by 58
Thompson, B. J., Jessen, T. N., Henry, L. K., Field, J. R., Gamble, K. L., Gresch, P. J., Carneiro, A. M. D., Horton, R. E., Chisnell, P. J., Belova, Y., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011920108 · Cited by 55
Self-citation5‐HT1B autoreceptor regulation of serotonin transporter activity in synaptosomes
Hagan, C. E., McDevitt, R. A., Liu, Y. K., Furay, A. R., & Neumaier, J. F. (2012) · Synapse · doi:10.1002/syn.21608 · Cited by 55
Multifaceted Regulations of the Serotonin Transporter: Impact on Antidepressant Response
Baudry, A., Pietri, M., Launay, J., Kellermann, O., & Schneider, B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00091 · Cited by 59
Sánchez, M. M., Alagbe, O., Felger, J. C., Zhang, J., Graff, A., Grand, A. P., Maestripieri, D., & Miller, A. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002025 · Cited by 54
Brust, T., Cayabyab, F. S., Zhou, N., & MacVicar, B. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4052-06.2006 · Cited by 51
Steiner, J. A., Carneiro, A. M., Wright, J., Matthies, H. J. G., Prasad, H. C., Nicki, C. K., Dostmann, W. R., Buchanan, C. C., Corbin, J. D., Francis, S. H., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-26 · Cited by 48
Self-citationRapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations
Hoover, B. R., Everett, C. V., Sorkin, A. D., & Zahniser, N. R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04522.x · Cited by 49
Control of serotonin transporter phosphorylation by conformational state
Zhang, Y., Turk, B. E., & Rudnick, G. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603282113 · Cited by 48
Mazei‐Robison, M. S., & Blakely, R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.012 · Cited by 47
Self-citationvan Heesch, F., Prins, J., Konsman, J. P., Korte-Bouws, G. A. H., Westphal, K. G. C., Rybka, J., Olivier, B., Kraneveld, A. D., & Korte, S. M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.014 · Cited by 47
Tian, W., Zhao, J., Lee, J., Akanda, M. R., Cho, J.-H., Kim, S.-K., Choi, Y., & Park, B. (2019) · Antioxidants · doi:10.3390/antiox9010027 · Cited by 47
Mortensen, O. V., Larsen, M. B., Prasad, B. M., & Amara, S. G. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0980 · Cited by 44
Brüning, C. A., Martini, F., Soares, S. M., Savegnago, L., Sampaio, T. B., & Nogueira, C. W. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.04.019 · Cited by 43
Pereira, S. V.-N., Ribeiro, J. D., Bertuzzo, C. S., & Marson, F. A. L. (2017) · Gene · doi:10.1016/j.gene.2017.07.068 · Cited by 42
Metadata
- Authors
- Zhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D.
- Affiliations
- Vanderbilt University (US)
- University of Vermont (US)
- Corresponding author
- Blakely, Randy D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 280
- Issue
- 16
- Pages
- 15649-15658
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2124241220
- Cited by
- 228
- References
- 70
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 11 · 2020: 9 · 2019: 8 · 2018: 11 · 2017: 5 · 2016: 13 · 2015: 15 · 2014: 12 · 2013: 17 · 2012: 20
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Vanderbilt University
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 68991, R01HL068991)
- National Institute of Mental Health (T32MH065782, T32-MH65782-02)
- National Institute on Drug Abuse (DA-07390, R01DA007390)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Keywords
- serotonin transporter, p38 MAPK, protein phosphatase 2A, anisomycin, adenosine receptors, protein kinase G, norepinephrine transporter, dopamine transporter, guanylyl cyclase inhibition, H8
- MeSH terms
- Animals, Cell Membrane, Cricetinae, Humans, Membrane Glycoproteins, Nerve Tissue Proteins, Phosphoprotein Phosphatases, Serotonin, Enzyme Activators, Membrane Transport Proteins, p38 Mitogen-Activated Protein Kinases, Serotonin Plasma Membrane Transport Proteins, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
